| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA712254 | F | Cytotoxicity against human Breast carcinoma MX-1 | Homo sapiens | 7 | cell-based format | Scientific Literature | ||
| 2. | ALA709623 | F | Cytotoxicity against human Breast carcinoma MX-1; Not determined | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 3. | ALA709624 | F | Percent tumor weight inhibition (TWI) in athymic mice at an optimal dose of 50 mg/kg in breast MX-1 cells | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA709625 | F | Percent tumor weight inhibition (TWI) in athymic mice at an optimal dose of 6 mg/kg in breast MX-1 cells | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA709626 | F | Evaluated for anticancer activity in tumor inhibition system MX-1 breast xenograph at a dose of 150 mg/kg; Number of Tested survived/number of control survived (5/10) | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA709627 | F | Evaluated for anticancer activity in tumor inhibition system MX-1 breast xenograph at a dose of 300 mg/kg; Number of Tested survived/number of control survived (1/6) | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA711523 | F | Evaluated for anticancer activity in tumor inhibition system MX-1 breast xenograph at a dose of 600 mg/kg; Number of Tested survived/number of control survived (0/6) | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA711524 | F | Evaluated for anticancer activity in tumor inhibition system MX-1 breast xenograph at a dose of 75 mg/kg; Number of Tested survived/number of control survived (4/6) | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA711525 | F | Evaluated for anticancer activity in tumor inhibition system MX-1 breast xenograph at dose 150 mg/kg | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA711526 | F | Evaluated for anticancer activity in tumor inhibition system MX-1 breast xenograph at dose 75 mg/kg | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA711527 | F | Evaluated for anticancer activity in tumor inhibition system MX-1 breast xenograph at a dose of 150mg/kg, value was reported as weight difference | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA711528 | F | Evaluated for anticancer activity in tumor inhibition system MX-1 breast xenograph at a dose of 75 mg/kg, value was reported as weight difference | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA711529 | F | Percent tumor weight inhibition (TWI) in athymic mice at an optimal dose of 100 mg/kg in breast MX-1 cells | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA711530 | F | Antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Optimal dose at 13.5 mg/kg/day | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA711531 | F | Antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Optimal dose at 40 mg/kg/day | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA709869 | F | Antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Optimal dose at 7.5 mg/kg/day | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA709870 | F | In vivo antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Maximum tested dose 90 mg/kg/day. | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA709871 | F | In vivo antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Optimal dose 1.3 mg/kg/day. | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA709872 | F | In vivo antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Optimal dose 10 mg/kg/day. | Homo sapiens | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA709873 | F | In vivo antitumor activity was measured on MX-1 human mammary carcinoma cells. TWI%=tumor weight inhibition. Optimal dose 11 mg/kg/day. | Homo sapiens | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!